A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...

Weight loss drugs like Ozempic bring health gains, but at what costs to relationships? Couples must face new challenges as ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...